LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 57.18 | 84.90 | 2174 | 6963 | 0.3122 | 0.6654 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 57.18 | 84.90 | 2857 | 6963 | 0.4103 | 0.7385 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 57.18 | 84.90 | 2887 | 6963 | 0.4146 | 0.7414 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 58.88 | 84.90 | 37 | 7291 | 0.0051 | -0.1213 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 58.88 | 84.90 | 3032 | 7291 | 0.4158 | 0.7447 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 58.88 | 84.90 | 106 | 7291 | 0.0145 | 0.0352 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 58.88 | 84.90 | 2278 | 7291 | 0.3124 | 0.6687 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 58.88 | 84.90 | 2961 | 7291 | 0.4061 | 0.7382 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 58.88 | 84.90 | 3007 | 7291 | 0.4124 | 0.7424 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 60.59 | 84.90 | 47 | 7641 | 0.0062 | -0.0871 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 60.59 | 84.90 | 3168 | 7641 | 0.4146 | 0.7463 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 60.59 | 84.90 | 95 | 7641 | 0.0124 | 0.0175 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 60.59 | 84.90 | 2391 | 7641 | 0.3129 | 0.6723 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 60.59 | 84.90 | 3096 | 7641 | 0.4051 | 0.7402 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 60.59 | 84.90 | 3144 | 7641 | 0.4114 | 0.7443 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 62.29 | 84.90 | 33 | 7934 | 0.0042 | -0.1344 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 62.29 | 84.90 | 3320 | 7934 | 0.4184 | 0.7508 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 62.29 | 84.90 | 98 | 7934 | 0.0124 | 0.0222 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 62.29 | 84.90 | 2499 | 7934 | 0.3150 | 0.6764 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 62.29 | 84.90 | 3240 | 7934 | 0.4083 | 0.7443 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 62.29 | 84.90 | 3287 | 7934 | 0.4143 | 0.7481 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.99 | 84.90 | 40 | 8212 | 0.0049 | -0.1078 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.99 | 84.90 | 3462 | 8212 | 0.4216 | 0.7545 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.99 | 84.90 | 118 | 8212 | 0.0144 | 0.0512 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.99 | 84.90 | 2601 | 8212 | 0.3167 | 0.6801 | MN20160318_Q02 | H20 |